HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of four new ...
Jul 31, 2025, 9:56 PM ETBio-Rad Laboratories, Inc. (BIO) Stock, BIO.B StockAI-Generated Earnings Calls Insights ...
Hosted on MSN
Bio-Rad outlines flat to 1% currency-neutral revenue growth for 2025 while expanding ddPCR partnerships
Earnings Call Insights: Bio-Rad Laboratories, Inc. (BIO) Q3 2025 Jonathan DiVincenzo, President & COO, reported that "revenue was consistent with our outlook and operating margin exceeded consensus, a ...
Bio-Rad Laboratories BIO recently announced the launch of four new Droplet Digital PCR (ddPCR) platforms. The newly introduced instruments include the company's QX Continuum ddPCR system, along with ...
Jonathan DiVincenzo, President & COO, reported that "revenue was consistent with our outlook and operating margin exceeded consensus, a testament to the discipline and agility of our teams in what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results